Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/25/2869506/0/en/HOOKIPA-Pharma-Announces-Pivotal-Phase-2-3-Trial-Design-for-HB-200-in-Combination-with-Pembrolizumab.html
https://www.globenewswire.com/news-release/2024/04/24/2868480/0/en/HOOKIPA-Pharma-Announces-FDA-Clearance-of-its-Investigational-New-Drug-Application-for-HB-700-for-the-Treatment-of-KRAS-Mutated-Cancers.html
https://www.globenewswire.com/news-release/2024/04/16/2864116/0/en/HOOKIPA-Pharma-Announces-Grant-of-Inducement-Award-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com/news-release/2024/04/10/2860632/0/en/HOOKIPA-Pharma-to-Host-Investor-Call-on-HB-200-and-Planned-Path-to-Registration.html
https://www.globenewswire.com/news-release/2024/03/22/2850878/0/en/HOOKIPA-Pharma-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Recent-Business-Highlights.html
https://www.globenewswire.com//news-release/2024/03/06/2841267/0/en/HOOKIPA-Pharma-to-Participate-in-Leerink-Partners-Global-Biopharma-Conference.html
https://www.globenewswire.com/news-release/2024/01/29/2818871/0/en/HOOKIPA-Pharma-Provides-Update-on-Business-Priorities-and-Oncology-Partnership-Programs.html
https://www.globenewswire.com//news-release/2024/01/16/2809721/0/en/HOOKIPA-Pharma-Appoints-Mark-Winderlich-as-Chief-Development-Officer-to-Lead-Clinical-Research-and-Development-Organization.html
https://www.globenewswire.com//news-release/2023/12/21/2799897/0/en/HOOKIPA-Pharma-Announces-21-25-Million-Equity-Investment-from-Gilead-Sciences.html
https://www.globenewswire.com/news-release/2023/11/20/2783124/0/en/HOOKIPA-Pharma-Announces-FDA-Clearance-of-its-Investigational-New-Drug-Application-for-HB-500-for-the-Treatment-of-Human-Immunodeficiency-Virus.html